Beijing, Beijing, China The leading representative office of defined VC is situated in the Beijing. The venture was found in Asia in China.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Harbour Biomed Among the most popular fund investment industries, there are Pharmaceutical, Energy. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the China Life Private Equity Investment, startups are often financed by Legend Capital, Advantech Capital, CDH Investments. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures China, Vertex Ventures, SWFI.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
| Fund Name | Location |
| Animal Capital | California, Los Angeles, United States |
| BF Holdings | Dudley, England, United Kingdom |
| Colony Latam Partners | - |
| DFE Capital Management | Arizona, Scottsdale, United States |
| Digital-Healthcare | England, Leeds, United Kingdom |
| Elevation Capital | Gurgaon, Haryana, India |
| ESM Japan | Fukui, Fukui Prefecture, Japan |
| Frankford Re | - |
| Haier Homecare | - |
| Helios Enterprises | - |
| Henley Ventures | British Columbia, Canada, Surrey |
| Luminary Media Nusantara | - |
| miHoYo | China, Shanghai |
| Rosemark Capital Group | New Jersey, Princeton, United States |
| Starwood Capital Group | Connecticut, Greenwich, United States |
| Symbiosis Group | - |
| Venrock Healthcare Partners | California, Palo Alto, United States |
| Zhejiang Lipin Hangye Xiehui | - |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Weikaier Pharmaceutical Technology | $69M | 02 Jan 2024 | Nanjing, Jiangsu, China | ||
Astronergy | $309M | 25 Jul 2023 | Hangzhou, Zhejiang, China | ||
Sunwoda Electric Vehicle Battery | $262M | 25 Jun 2023 | Shanghai, Shanghai, China | ||
Care Medical | 14 Jun 2023 | Suzhou, Jiangsu, China | |||
Yingke Biopharmaceutical | $46M | 01 Jun 2023 | Taizhou, Jiangsu, China | ||
VJTbio | 22 May 2023 | Haidian, Beijing, China | |||
Svision | $46M | 09 Mar 2023 | Huizhou, Guangdong Province, China | ||
Fushoukang | $15M | 28 Dec 2022 | Shanghai, China | ||
MAXVAX | $46M | 07 Dec 2022 | Shuangliu, Sichuan, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Weikaier Pharmaceutical Technology | $69M | 02 Jan 2024 | Nanjing, Jiangsu, China | ||
Astronergy | $309M | 25 Jul 2023 | Hangzhou, Zhejiang, China | ||
Sunwoda Electric Vehicle Battery | $262M | 25 Jun 2023 | Shanghai, Shanghai, China | ||
Care Medical | 14 Jun 2023 | Suzhou, Jiangsu, China | |||
Yingke Biopharmaceutical | $46M | 01 Jun 2023 | Taizhou, Jiangsu, China | ||
VJTbio | 22 May 2023 | Haidian, Beijing, China | |||
Svision | $46M | 09 Mar 2023 | Huizhou, Guangdong Province, China | ||
Fushoukang | $15M | 28 Dec 2022 | Shanghai, China | ||
MAXVAX | $46M | 07 Dec 2022 | Shuangliu, Sichuan, China |
